Fundraising FoxViking Global Investors — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin Capital+5 more
Lightmatter is a product development firm that partners with companies to design and build digital products from concept through launch.
Developer ToolsHealthtechSaaSMountain View, US
Greg Hausheer(CEO and Founder)inBen Beecher(CTO and Founder)inNicholas Harris(Founder)inThomas Graham(Founder)inTrevor Moorman(COO)inMollie Fleury(Chief of Staff)in
Co-investorsGV (Google Ventures)Spark CapitalFidelity InvestmentsLockheed Martin VenturesT. Rowe Price
Pearl Health provides tools, intelligence, and support to primary care providers and healthcare organizations to deliver proactive care within value-based care models.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechNew York, US
Michael Kopko(Founder)inAnkit Patel(Founder)
BoardJeffrey De Flavio(Executive Chairman)inVineeta Agarwala(Director)inScott Kupor(Director)inJeff DeFlavio(Director)in
Co-investorsAndreessen HorowitzAlleyCorpAlumni VenturesBasecamp FundFloating PointGaingels+6 more
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.